, Management of adults with essential hypertension, HAS, 2005.

, Drug treatment of type 2 diabetes, HAS, 2006.

, Clinical management of primary hypertension in adults, 2011.

G. Mancia, S. Laurent, and E. Agabiti-rosei, Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document, Blood Press, vol.18, pp.308-355, 2009.

J. A. Staessen, J. G. Wang, and L. Thijs, Cardiovascular protection and blood pressure reduction: a meta-analysis, Lancet, vol.358, pp.1305-1320, 2001.

R. Boussageon, T. Bejan-angoulvant, and M. Saadatian-elahi, Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials, BMJ, vol.343, p.4169, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00698409

M. Briel, I. Ferreira-gonzalez, and J. J. You, Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis, BMJ, vol.338, p.92, 2009.

P. M. Kearney, M. Whelton, and K. Reynolds, Worldwide prevalence of hypertension: a systematic review, J Hypertens, vol.22, pp.11-19, 2004.

M. Joffres, E. Falaschetti, and C. Gillespie, Hypertension prevalence, awareness, treatment and control in national surveys from England, the USA and Canada, and correlation with stroke and ischaemic heart disease mortality: a cross-sectional study, BMJ Open, vol.3, p.3423, 2013.

J. Lebeau, BMJ Open, vol.6, p.10639, 2016.

H. Godet-mardirossian, X. Girerd, and M. Vernay, , 2006.

, Eur J Prev Cardiol, vol.19, pp.213-233, 2012.

Y. R. Wang, G. C. Alexander, and R. S. Stafford, Outpatient hypertension treatment, treatment intensification, and control in Western Europe and the United States, Arch Intern Med, vol.167, pp.141-148, 2007.

G. Grassi, R. Cifkova, and S. Laurent, Blood pressure control and cardiovascular risk profile in hypertensive patients from central and eastern European countries: results of the BP-CARE study, Eur Heart J, vol.32, pp.218-243, 2011.

C. Mounier-vehier, G. Amah, and J. Covillard, Management of essential arterial hypertension and cardiovascular risk levels. Observation in general medicine: national PHENOMEN study, Arch Mal Coeur Vaiss, vol.95, pp.667-72, 2002.

S. H. Naderi, J. P. Bestwick, and D. S. Wald, Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients, Am J Med, vol.125, pp.882-889, 2012.

L. S. Phillips, W. T. Branch, and C. B. Cook, Clinical inertia, Ann Intern Med, vol.135, pp.825-859, 2001.

E. C. Okonofua, K. N. Simpson, and A. Jesri, Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals, Hypertension, vol.47, pp.345-51, 2006.

S. E. Andrade, J. H. Gurwitz, and T. S. Field, Hypertension management: the care gap between clinical guidelines and clinical practice, Am J Manag Care, vol.10, pp.481-487, 2004.

N. Rodondi, T. Peng, and A. J. Karter, Therapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus, Ann Intern Med, vol.144, pp.475-84, 2006.

M. Cabana, C. Sand, and N. Powe, Why Don't physicians follow clinical practice guidelines? A framework for improvement, JAMA, vol.15, pp.1458-65, 1999.

J. P. Lebeau, J. S. Cadwallader, and I. Auger-aubin, The concept and definition of therapeutic inertia in hypertension in primary care: a qualitative systematic review, BMC Fam Pract, vol.15, p.130, 2014.

M. M. Safford, R. Shewchuk, and H. Qu, Reasons for not intensifying medications: differentiating 'clinical inertia' from appropriate care, J Gen Intern Med, vol.22, pp.1648-55, 2007.

C. E. Nwachuku, A. Bastien, and J. A. Cutler, Management of high blood pressure in clinical practice: perceptible qualitative differences in approaches utilized by clinicians, J Clin Hypertens, vol.10, pp.822-831, 2008.

F. Howes, E. Hansen, and D. Williams, Barriers to diagnosing and managing hypertension-a qualitative study in Australian general practice, Aust Fam Physician, vol.39, pp.511-527, 2010.

R. Hogan and R. Blake, John Holland's vocational typology and personality theory, J Vocat Behav, vol.55, pp.41-56, 1999.

S. J. Vitell, S. L. Nwachukwu, and J. H. Barnes, The effects of culture on ethical decision-making: an application of Hofstede's typology, Citation classics from the Journal of Business Ethics: celebrating the first thirty years of publication, pp.119-148, 2013.

I. Kamhalová, P. Halama, and J. Gurán-?-ková, Affect regulation and decision making in health-care professionals: typology approach, Stud Psychol, vol.55, pp.19-31, 2013.

S. B. Wackerbarth, The Alzheimer's family caregiver as decision maker: a typology of decision styles, J Appl Gerontol, vol.21, pp.314-346, 2002.

S. Kluge, Empirically grounded construction of types and typologies in qualitative social research, Forum: Qualitative Social Research, 2000.

M. Q. Patton, Qualitative research and evaluation methods: integrating theory and practice, 2014.

L. Ayres and K. A. Knafl, The Sage encyclopedia of qualitative research methods, Given LM, pp.900-901, 2008.

D. Pouchain, M. Lièvre, and D. Huas, EffectS of a multifaceted intervention on CArdiovascular risk factors in high-risk hyPErtensive patients: the ESCAPE trial, a pragmatic cluster randomized trial in general practice, Trials, vol.14, p.318, 2013.
URL : https://hal.archives-ouvertes.fr/hal-01619287

S. A. Oliveria, P. Lapuerta, and B. D. Mccarthy, Physician-related barriers to the effective management of uncontrolled hypertension, Arch Intern Med, vol.162, pp.413-433, 2002.

J. S. Lin, O. Connor, E. A. Evans, and C. V. , Behavioral counseling to promote a healthy lifestyle for cardiovascular disease prevention in persons with cardiovascular risk factors: an updated systematic evidence review for the U.S. preventive services task force, Agency for Healthcare Research and Quality (US), 2014.

R. R. Wing, P. Bolin, and F. L. Brancati, for the Look AHEAD Research Group. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes, N Engl J Med, vol.369, pp.145-54, 2013.

D. Davis, P. Mazmanian, and M. Fordis, Accuracy of physician self-assessment compared with observed measures of competence: a systematic review, JAMA, vol.9, pp.1094-102, 2006.

G. Parati, G. S. Stergiou, and R. Asmar, ESH Working Group on Blood Pressure Monitoring. European Society of Hypertension practice guidelines for home blood pressure monitoring, J Hum Hypertens, vol.24, pp.779-85, 2010.

J. Blacher, J. Halimi, and O. Hanon, Management of hypertension in adults: the 2013 French Society of Hypertension guidelines, Fundam Clin Pharmacol, vol.28, pp.1-9, 2014.

T. Van-der-weijden, L. B. Bos, and M. S. Koelewijn-van-loon, Primary care patients' recognition of their own risk for cardiovascular disease: implications for risk communication in practice, Curr Opin Cardiol, vol.23, pp.471-477, 2008.

L. S. Phillips and J. G. Twombly, It's time to overcome clinical inertia, Ann Intern Med, vol.148, pp.783-788, 2008.

C. M. Boyd, S. Vijan, and R. C. Sherrick, Will running the numbers first violate the principles of patient-centered care?, Ann Intern Med, vol.149, pp.840-841, 2008.

J. Lebeau, D. Pouchain, and D. Huas, ESCAPE-ancillary blood pressure measurement study: end-digit preference in blood pressure measurement within a cluster-randomized trial, Blood Press Monit, vol.16, pp.74-83, 2011.

P. J. Nietert, A. M. Wessell, and C. Feifer, Effect of terminal digit preference on blood pressure measurement and treatment in primary care, Am J Hypertens, vol.19, pp.147-52, 2006.

J. R. Banegas, K. Lundelin, and M. De-la-figuera, Physician perception of blood pressure control and treatment behavior in high-risk hypertensive patients: a cross-sectional study, PLoS ONE, vol.6, p.24569, 2011.

R. Nicodème, A. Albessard, and J. Amar, Poor blood pressure control in general practice: in search of explanations, Arch Cardiovasc Dis, vol.102, pp.477-83, 2009.

H. Ogawa, M. Nakayama, and T. Morimoto, Low-dose aspirin for primary prevention of atherosclerosis events in patients with type 2 diabetes. A randomized controlled trial, JAMA, vol.300, pp.2134-2175, 2008.

J. Belch, A. Maccuish, and I. Campbell, The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease, BMJ, vol.337, pp.1840-50, 2008.

, Prescrire Rédaction. [Hypertension artérielle, quels seuils et pour quoi faire?, Revue Prescrire, vol.26, p.843, 2006.

F. A. Mcalister, K. Wilkins, and M. Joffres, Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades, CMAJ, vol.183, pp.1007-1020, 2011.